MASSIVE BLOOD TRANSFUSION AND
COMPLICATION OF BLOOD TRANSFUSION
Farshana jabin, Hepsibah solomon
M.Sc.Anesthesia Technology
DEFINITIO
N
• Various definitions of massive blood transfusion (MPT) have been
published in the medical literature such as;
• Massive blood transfusion defined as the transfusion of more than 10 unit
of PRBS in a 24 hour period
• Also defined as the replacement of more than 50% of a patient’s blood
volume in 12 to 24 hours
GENERAL
INDICATION
• In hemorrhagic shock and ongoing hemorrhage and anemia (to increase
oxygen carrying capacity
• Severe trauma
• Ruptured aortic aneurysm
• Surgery
• Obstetric complication
GOAL OF MASSIVE TRANSFUSION PROTOCOL
• Early recognition of blood loss
• Maintenance of tissue perfusion and oxygenation by restoration of blood volume and
haemoglobin
• Arrest of bleeding in combination with use of early surgical or radiological intervention
• Judicious use of blood components therapy to correct coagulopathy
MTP are designed to interrupt the triad of acidosis, hypothermia, and
coagulopathy that develops with massive transfusion there by improving outcome
• A MASSIVETRANSFUSION PACK CONTAINS
1. 6 units red blood cells
2. 4 units plasma
3. 1 apheresis platelet unit
4. 1cryopresipitate pooled unit
RBC and Plasma delivered first, with a goal delivery time of 15 min
TARGET OF MASSIVE TRANSFUSION PROTOCOL
• Mean arterial pressure(MAP) around 60mmhg, systolic arterial pressure 80-100 mmhg
• Hb 7-9 g/dl
• INR <1.5 ;Activated PTT <42
• Fibrinogen >1g/dl
• Platelets >50*10^9/dl
• pH >7.2
• Core temperature >35 degree celcius
• Ionized calcium >1.1 mmol/L
MASSIVE TRANSFUSION PROTOCOL
Call blood bank and inform that MTP to be initiated
Divide team into ABC, Assign each team to do specific task,
• TEAM A :Administer blood components
• TEAM B : Record keeping, sampling ,labeling, writing notes
• TEAM C: Go to blood bank and get blood components
PRESSURIZED RAPIDTRANSFUSION
• Ensures blood component reaches into patient’s body
on time
• Ensure infusion matched blood loss there by increases
chance of survival
• Has in line warmer that decreases chance of
hypothermia and there by coagulation problems are
taken care of and hemostasis achieved
ROUND 1
• Give InjTranexemic acid1gm IV stat and then 8 hourly
• Send CBC, Coagulation profile, Fibrinogen level and ABG
• Connect pressurized rapid trasfuser
• In many trauma situations, there is excessive blood loss, and transfusion needed before the ability
to perform pre transfusion testing. in these cases, group O RBCs and AB plasma product should be
given until the patients blood type can be determined
TRANSFUSE:-
• 4 UNIT PRBC
• 2 UNIT FFP
If no improvement start round 2
ROUND 2
TRANSFUSE:-
• 4 UNIT PRBC
• 4 UNIT FFP
• 1 UNIT SDP OR 6 UNIT PRP
Collect lab report to evaluate coagulopathy and acidosis
Give Inj Calcium gluconate 10 ml slow IV to prevent tetany
Cryoprecipitate infusion if fibrinogen level <100 mg/dl
If no improvement then, start round 3
ROUND 3
• Repeat round + FactorVIIa
Indication to giveFactorVIIa
• Surgical hemostasis
• Temperature 37 degree celcius and ph has been stabilized but patient is
still bleeding
COMPLICATION
• ACIDOSIS
• HYPERKALEMIA
• HYPOTHERMIA
• CITRATE TOXICITY
• HYPOCALCAEMIA
• USUAL TRANSFUSION REACTION PROBLEM
• LATE COMPLICATIONS
THANKYOU

MASSIVE BLOOD TRANSFUSION AND COMPLICATION OF BLOOD TRANSFUSION.pptx

  • 1.
    MASSIVE BLOOD TRANSFUSIONAND COMPLICATION OF BLOOD TRANSFUSION Farshana jabin, Hepsibah solomon M.Sc.Anesthesia Technology
  • 2.
    DEFINITIO N • Various definitionsof massive blood transfusion (MPT) have been published in the medical literature such as; • Massive blood transfusion defined as the transfusion of more than 10 unit of PRBS in a 24 hour period • Also defined as the replacement of more than 50% of a patient’s blood volume in 12 to 24 hours
  • 3.
    GENERAL INDICATION • In hemorrhagicshock and ongoing hemorrhage and anemia (to increase oxygen carrying capacity • Severe trauma • Ruptured aortic aneurysm • Surgery • Obstetric complication
  • 4.
    GOAL OF MASSIVETRANSFUSION PROTOCOL • Early recognition of blood loss • Maintenance of tissue perfusion and oxygenation by restoration of blood volume and haemoglobin • Arrest of bleeding in combination with use of early surgical or radiological intervention • Judicious use of blood components therapy to correct coagulopathy MTP are designed to interrupt the triad of acidosis, hypothermia, and coagulopathy that develops with massive transfusion there by improving outcome
  • 5.
    • A MASSIVETRANSFUSIONPACK CONTAINS 1. 6 units red blood cells 2. 4 units plasma 3. 1 apheresis platelet unit 4. 1cryopresipitate pooled unit RBC and Plasma delivered first, with a goal delivery time of 15 min
  • 7.
    TARGET OF MASSIVETRANSFUSION PROTOCOL • Mean arterial pressure(MAP) around 60mmhg, systolic arterial pressure 80-100 mmhg • Hb 7-9 g/dl • INR <1.5 ;Activated PTT <42 • Fibrinogen >1g/dl • Platelets >50*10^9/dl • pH >7.2 • Core temperature >35 degree celcius • Ionized calcium >1.1 mmol/L
  • 8.
    MASSIVE TRANSFUSION PROTOCOL Callblood bank and inform that MTP to be initiated Divide team into ABC, Assign each team to do specific task, • TEAM A :Administer blood components • TEAM B : Record keeping, sampling ,labeling, writing notes • TEAM C: Go to blood bank and get blood components
  • 9.
    PRESSURIZED RAPIDTRANSFUSION • Ensuresblood component reaches into patient’s body on time • Ensure infusion matched blood loss there by increases chance of survival • Has in line warmer that decreases chance of hypothermia and there by coagulation problems are taken care of and hemostasis achieved
  • 10.
    ROUND 1 • GiveInjTranexemic acid1gm IV stat and then 8 hourly • Send CBC, Coagulation profile, Fibrinogen level and ABG • Connect pressurized rapid trasfuser • In many trauma situations, there is excessive blood loss, and transfusion needed before the ability to perform pre transfusion testing. in these cases, group O RBCs and AB plasma product should be given until the patients blood type can be determined TRANSFUSE:- • 4 UNIT PRBC • 2 UNIT FFP If no improvement start round 2
  • 11.
    ROUND 2 TRANSFUSE:- • 4UNIT PRBC • 4 UNIT FFP • 1 UNIT SDP OR 6 UNIT PRP Collect lab report to evaluate coagulopathy and acidosis Give Inj Calcium gluconate 10 ml slow IV to prevent tetany Cryoprecipitate infusion if fibrinogen level <100 mg/dl If no improvement then, start round 3
  • 12.
    ROUND 3 • Repeatround + FactorVIIa Indication to giveFactorVIIa • Surgical hemostasis • Temperature 37 degree celcius and ph has been stabilized but patient is still bleeding
  • 13.
    COMPLICATION • ACIDOSIS • HYPERKALEMIA •HYPOTHERMIA • CITRATE TOXICITY • HYPOCALCAEMIA • USUAL TRANSFUSION REACTION PROBLEM • LATE COMPLICATIONS
  • 14.